P.L. 2009, c. 307, approved January 18, 2010, and codified at N.J.S.A. 24:6I-1 et seq., is the New Jersey

Compassionate Use Medical Marijuana Act (the Act). The Act is the enabling authority for the Division of

Medicinal Marijuana within the Department of Health.

Pursuant to N.J.S.A. 24-6I-12, the Department shall report to the Governor and to the Legislature on a biennial basis to assess the following factors:

• Whether the maximum amount of medical marijuana allowed pursuant to the Act is sufficient to meet

the needs of qualified patients;

• Whether any alternative treatment center has charged excessive prices for the marijuana that the

center dispensed; and

• Whether there are sufficient numbers of alternative treatment centers to meet the needs of qualified

patients.

Pursuant to that statutory charge, the Department has assessed those factors as part of this report and the findings are presented in the following document.

The report covers 2016 and 2017 for some measures. Additionally, due to the expansion in the program that occurred in 2018 and that significantly altered market conditions, the Department also utilized 2018 data for several measures. The dates for each measure are noted in the report.